Texas Medical Association et al v. U.S. Department of Health and Human Services (TMA I)
District Court: U.S. District Court for the Eastern District of Texas Status: Decided
The Texas Medical Association (TMA) filed a complaint against the U.S. Department of Health and Human Services, Department of Labor, Department of the Treasury, Office of Personnel […]
Georgia College Of Emergency Physicians et al. v. U.S. Department Of Health And Human Services et al.
District Court: U.S. District Court for the Northern District of Georgia, Atlanta Division Status: Decided
On December 23, 2021, Georgia College Of Emergency Physicians (GCEP), a professional group, filed suit against the US Department of Health and Human Services, Department […]
American Society of Anesthesiologists v. U.S. Department of Health and Human Services
District Court: U.S. District Court for the Northern District of Illinois Status: Decided
On December 22, 2021, the American Society of Anesthesiologists, American College of Emergency Physicians, and American College of Radiology filed suit against the US Department […]
Association of Air Medical Services v. U.S. Department of Health and Human Services / American Medical Association et al. v. U.S. Department Of Health and Human Services et al.
District Court: United States District Court for the District of Columbia Status: Decided
In late 2021, less than one month apart, the Association of Air Medical Services (filed November 16, 2021) and later the American Medical Association and […]
Haller v. U.S. Department of Health and Human Services
District Court: Eastern District of New York Status: Decided
The complaint alleges that major parts of the No Surprises Act are unconstitutional. Specifically, Dr. Haller claims that the federal IDR process and prohibition of […]
LifeNet v. U.S. Department of Health and Human Services
District Court: Eastern District of Texas Status: Decided
LifeNet, an air ambulance provider based in Texas that transports patients in Louisiana and Arkansas, filed suit to challenge the No Surprises Act, claiming the government treats […]
Brown et al. v. Hartford Healthcare
District Court: Superior Court Judicial District of Hartford Status: Pending
In a class action filed by seven Connecticut consumers in state court, plaintiffs allege that Hartford Healthcare acquired a monopoly on acute inpatient hospital services […]
PhRMA v. Stolfi
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Uriel Pharmacy v. Advocate Aurora Health
District Court: Eastern District of Wisconsin Status: Pending
Brought by Uriel Pharmacy, a self-insured employer, the federal lawsuit alleges Advocate forced insurers to enter all-or-nothing and anti-tiering and anti-steering contract terms. In addition, […]
In re Mission Health Antitrust Litigation
District Court: Western District of North Carolina Status: Pending
Originally filed in federal district court by the city of Brevard, North Carolina (City of Brevard, North Carolina v. HCA Healthcare and Mission Health System), […]
Davis et al. v. HCA Healthcare and Mission Health System
District Court: North Carolina Superior Court (Buncombe County) Status: Pending
The class action lawsuit filed in North Carolina state court against HCA Healthcare and Mission Health alleges anticompetitive practices in violation of the North Carolina […]
Community Hospitals and Wellness Centers v. State of Ohio
District Court: Common Pleas Court of Williams County Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the […]
Pharmaceutical Care Management Association (PCMA) v. Mulready
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
PhRMA and BIO v. Sandoval
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of […]
Association for Accessible Medicines v. Frosh
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic […]
PhRMA v. David
District Court: Eastern District of California Status: Decided
PhRMA challenged California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, and […]